ABCL AbCellera Biologics

AbCellera to Report Full Year 2024 Financial Results on February 27, 2025

VANCOUVER, British Columbia--(BUSINESS WIRE)--

(Nasdaq: ABCL) will announce its full year 2024 financial results on Thursday, February 27, 2025, and hold an earnings conference call at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) the same day.

A live audio webcast of the earnings conference may be accessed through a link that will be posted on . A replay will be available through the same link following the conference call.

About AbCellera Biologics Inc.

(Nasdaq: ABCL) discovers and develops antibody medicines for indications across therapeutic areas including cancer, metabolic and endocrine conditions, and autoimmune disorders. AbCellera’s engine integrates technology, data science, infrastructure, and interdisciplinary teams to solve the most challenging antibody discovery problems. AbCellera is focused on advancing an internal pipeline of first-in-class and best-in-class programs and collaborating on innovative drug development programs with partners. For more information, please visit .

EN
21/01/2025

Underlying

ABCLAbCellera Biologics

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on AbCellera Biologics

 PRESS RELEASE
Free
ABCL AbCellera Biolo...

AbCellera to Report Full Year 2024 Financial Results on February 27, 2...

VANCOUVER, British Columbia--(BUSINESS WIRE)-- (Nasdaq: ABCL) will announce its full year 2024 financial results on Thursday, February 27, 2025, and hold an earnings conference call at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) the same day. A live audio webcast of the earnings conference may be accessed through a link that will be posted on . A replay will be available through the same link following the conference call. About AbCellera Biologics Inc. (Nasdaq: ABCL) discovers and develops antibody medicines for indications across therapeutic areas including cancer, metabolic and ...

12h / 48m 1 EN
 PRESS RELEASE
Free
ABCL AbCellera Biolo...

AbCellera Expands Collaboration with AbbVie to Develop Novel T-Cell En...

VANCOUVER, British Columbia--(BUSINESS WIRE)-- (Nasdaq: ABCL) announced today that it has expanded its existing collaboration with AbbVie Inc. (NYSE: ABBV) to include the discovery of T-cell engagers (TCE) in oncology. The expansion builds upon the successful partnership and includes access to AbCellera’s TCE platform to develop therapeutic antibodies for tumor targets. “We are pleased to broaden our AbbVie collaboration and look forward to using AbCellera’s TCE platform to bring novel cancer immunotherapies to patients in need,” said Carl Hansen, Ph.D., founder and CEO of AbCellera. Und...

January 13, 2025 1 EN
Jonathan Moreland
  • Jonathan Moreland
Free Trial
RMAX RE/MAX Holdings...
MYE Myers Industrie... ... (+53)

InsiderInsights Weekly Report: December 7, 2024

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

RMAX RE/MAX HOLDINGS INC.
MYE MYERS INDUSTRIES INC.
MPAA MOTORCAR PARTS OF AMERICA INC.
LTRX LANTRONIX INC.
HRZN HORIZON TECHNOLOGY FINANCE CORP.
GLP GLOBAL PARTNERS LP
FCN FTI CONSULTING INC.
CVGI COMMERCIAL VEHICLE GROUP INC.
BRKR BRUKER CORPORATION
AXSM AXSOME THERAPEUTICS
ACRS ACLARIS THERAPEUTICS INC.
MEDP MEDPACE HOLDINGS INC.
ENPH ENPHASE ENERGY INC.
ISTR INVESTAR HOLD
PETS PETMED EXPRESS INC.
FRD FRIEDMAN INDUSTRIES INC.
VVV VALVOLINE INC.
SACH SACHEM CAPITAL
DMLP DORCHESTER MINERALS L.P.
MBIN MERCHANTS BANCORP
LILA LIBERTY LATIN AMERICA A
HHS HARTE-HANKS INC.
ETST EARTH SCIENCE TECH
TCPC BLACKROCK TCP CAPITAL CORP.
GRWG GROWGENERATION
PCB PACIFIC CITY FINANCIAL CORP
FBRX FORTE BIOSCIENCES INC
VRM VROOM
ONEW INC.
SSSS ONEWATER MARINE
ABCL SUTTER ROCK CAPITAL CORP.
FTHM ABCELLERA BIOLOGICS
IMNM FATHOM HOLDINGS
WOLF IMMUNOME
CLVT WOLFSPEED INC
RWAY CLARIVATE PLC
ANTX RUNWAY GROWTH FINANCE CORP
NXGL AN2 THERAPEUTICS INC
HR NEXGEL INC
CARV HEALTHCARE TRUST OF AMERICA INC.
BIGZ CARVER BANCORP INC
MODD BLACKROCK INNOVATION AND GROWTH TST
PFHC MODULAR MEDICAL INC
GRNT PROFRAC HLDG CORP
NCDL GRANITE RIDGE RESOURCES INC
SPRU NUVEEN CHURCHILL DIRECT LENDING CORP
CATX SPRUCE POWER HOLDING CORP
ASMB PERSPECTIVE THERAPEUTICS
FGF INC.
GWAV ASSEMBLY BIOSCIENCES INC
FG FINANCIAL GROUP
INC.
GREENWAVE TECHNOLOGY SOLUTIONS INC
12/07/24 December 7, 2024 1 EN
Jonathan Moreland
  • Jonathan Moreland
Free Trial
PSEC Prospect Capita...
OPK OPKO Health In... ... (+56)

Monthly Insider Special Screens: December 1, 2024

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

PSEC PROSPECT CAPITAL CORPORATION
OPK OPKO HEALTH INC.
NMFC NEW MOUNTAIN FINANCE CORPORATION
MCHX MARCHEX INC. CL B
LTRX LANTRONIX INC.
HSII HEIDRICK & STRUGGLES INTERNATIONAL INC.
HASI
I3N HANNON ARMSTRONG SUSTAINABLE INFRASTRUCTURE CAPITAL INC.
EXAS CHART INDUSTRIES INC.
EL EXACT SCIENCES CORPORATION
CROX ESTEE LAUDER COMPANIES INC. CLASS A
CNC CROCS INC.
BRKR CENTENE CORPORATION
APPS BRUKER CORPORATION
AVNW DIGITAL TURBINE
AIN AVIAT NETWORKS
CMCO ALBANY INTERNATIONAL CORP. CLASS A
ENPH COLUMBUS MCKINNON CORPORATION
HTLD ENPHASE ENERGY INC.
SACH HEARTLAND EXPRESS INC.
DMLP SACHEM CAPITAL
HLNE DORCHESTER MINERALS L.P.
ANGI HAMILTON LANE INCORPORATED CLASS A
MBIN ANGI INC. CLASS A
LILA MERCHANTS BANCORP
FF LIBERTY LATIN AMERICA A
MEC FIRST MINING GOLD
NOVA MAYVILLE ENGINEERING
GRWG SUNNOVA ENERGY INTERNATIONAL
PCB GROWGENERATION
CLDX PACIFIC CITY FINANCIAL CORP
FBRX CELLDEX THERAPEUTICS INC.
TFC FORTE BIOSCIENCES INC
ONEW TRUIST FINANCIAL CORP
ARRY ONEWATER MARINE
SSSS ARRAY TECHNOLOGIES
ABCL SUTTER ROCK CAPITAL CORP.
CSU ABCELLERA BIOLOGICS
IMNM CAPITAL SENIOR LIVING
GRNT IMMUNOME
PFBX GRANIT SKOPKE
TRIN PEOPLES FINANCIAL CORP. (MISSISSIPPI)
ZETA TRINITY CAPITAL INC
RWAY ZETA GLOBAL HLDGS CORP
ANTX RUNWAY GROWTH FINANCE CORP
NXGL AN2 THERAPEUTICS INC
CALC NEXGEL INC
DBD CALCIMEDICA INC.
CATX DIEBOLD NIXDORF INCORPORATED
MDRR PERSPECTIVE THERAPEUTICS
PDYN INC.
DC MEDALIST DIVERSIFIED REIT INC.
AGFY SARCOS TECHNOLOGY AND ROBOTICS CORP
ETS DAKOTA GOLD CORP.
AGRIFY CORPORATION
ENTERASYS NETWORKS INC /DE/
12/02/24 December 2, 2024 1 EN
Jonathan Moreland
  • Jonathan Moreland
Free Trial
RMAX RE/MAX Holdings...
PSEC Prospect Capita... ... (+53)

InsiderInsights Weekly Report: November 30, 2024

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

RMAX RE/MAX HOLDINGS INC.
PSEC PROSPECT CAPITAL CORPORATION
MYE MYERS INDUSTRIES INC.
MPAA MOTORCAR PARTS OF AMERICA INC.
LTRX LANTRONIX INC.
GLP GLOBAL PARTNERS LP
EL ESTEE LAUDER COMPANIES INC. CLASS A
BRKR BRUKER CORPORATION
AXSM AXSOME THERAPEUTICS
APPS DIGITAL TURBINE
ACRS ACLARIS THERAPEUTICS INC.
MEDP MEDPACE HOLDINGS INC.
ENPH ENPHASE ENERGY INC.
ISTR INVESTAR HOLD
FRD FRIEDMAN INDUSTRIES INC.
SACH SACHEM CAPITAL
MBIN MERCHANTS BANCORP
LILA LIBERTY LATIN AMERICA A
FF FIRST MINING GOLD
ETST EARTH SCIENCE TECH
TCPC BLACKROCK TCP CAPITAL CORP.
NOVA SUNNOVA ENERGY INTERNATIONAL
GRWG GROWGENERATION
PCB PACIFIC CITY FINANCIAL CORP
FBRX FORTE BIOSCIENCES INC
TFC TRUIST FINANCIAL CORP
ONEW ONEWATER MARINE
ARRY ARRAY TECHNOLOGIES
SSSS SUTTER ROCK CAPITAL CORP.
ABCL ABCELLERA BIOLOGICS
CSU CAPITAL SENIOR LIVING
IMNM IMMUNOME
GRNT GRANIT SKOPKE
OSCR OSCAR HEALTH
WOLF WOLFSPEED INC
CLVT CLARIVATE PLC
ZETA ZETA GLOBAL HLDGS CORP
RWAY RUNWAY GROWTH FINANCE CORP
ANTX AN2 THERAPEUTICS INC
CGBD TCG BDC
NXGL INC.
HR NEXGEL INC
CARV HEALTHCARE TRUST OF AMERICA INC.
PFHC CARVER BANCORP INC
EP PROFRAC HLDG CORP
CATX EMPIRE PETROLEUM CORP
ASMB PERSPECTIVE THERAPEUTICS
DC INC.
FGF ASSEMBLY BIOSCIENCES INC
AGFY DAKOTA GOLD CORP.
FG FINANCIAL GROUP
INC.
AGRIFY CORPORATION
12/01/24 December 1, 2024 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch